Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cytek Biosciences (CTKB) Other Non Operating Income (2020 - 2025)

Historic Other Non Operating Income for Cytek Biosciences (CTKB) over the last 6 years, with Q3 2025 value amounting to $1.3 million.

  • Cytek Biosciences' Other Non Operating Income fell 5651.89% to $1.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.0 million, marking a year-over-year increase of 2606.39%. This contributed to the annual value of $4.5 million for FY2024, which is 4273.8% down from last year.
  • Cytek Biosciences' Other Non Operating Income amounted to $1.3 million in Q3 2025, which was down 5651.89% from $3.7 million recorded in Q2 2025.
  • In the past 5 years, Cytek Biosciences' Other Non Operating Income registered a high of $3.7 million during Q2 2025, and its lowest value of -$615000.0 during Q1 2021.
  • Over the past 5 years, Cytek Biosciences' median Other Non Operating Income value was $823000.0 (recorded in 2024), while the average stood at $1.1 million.
  • As far as peak fluctuations go, Cytek Biosciences' Other Non Operating Income plummeted by 31243.24% in 2021, and later skyrocketed by 618474.58% in 2025.
  • Quarter analysis of 5 years shows Cytek Biosciences' Other Non Operating Income stood at -$399000.0 in 2021, then surged by 624.06% to $2.1 million in 2022, then surged by 52.75% to $3.2 million in 2023, then tumbled by 84.63% to $491000.0 in 2024, then skyrocketed by 173.73% to $1.3 million in 2025.
  • Its Other Non Operating Income was $1.3 million in Q3 2025, compared to $3.7 million in Q2 2025 and $3.5 million in Q1 2025.